Scientific Sessions 2024  /  Applying Advances in Risk Prediction to PREVENT CV Disease  /  External validation of PREVENT in a large health system
Logo

American Heart Association

  18
  0

Final ID:

External validation of PREVENT in a large health system

  • Go, Alan  ( KAISER PERMANENTE NORTHERN CAL , Pleasanton , California , United States )
    • Author Disclosures:
    Alan Go: DO have relevant financial relationships ; Research Funding (PI or named investigator):Bristol Myers-Squibb:Active (exists now) ; Research Funding (PI or named investigator):Pfizer:Past (completed)
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Applying Advances in Risk Prediction to PREVENT CV Disease

Monday, 11/18/2024 , 01:30PM - 02:45PM

Cardiovascular Seminar

More abstracts on this topic:
Using risk prediction to guide the use of non-statin pharmacotherapies

Pandey Ambarish, Berg David

Case: managing a patient with discordant ASCVD and HF risk

Ostrominski John

More abstracts from these authors:
Cardiovascular Risk Factors and Predicted Risks Across Asian American, Native Hawaiian and other Pacific Islander Subgroups: The PANACHE Study

Parikh Rishi, Go Alan, Lo Joan, Ambrosy Andrew, Tan Thida, Alexeeff Stacey, Howick Connor, Daida Yihe

Environmental Justice and Atherosclerotic Cardiovascular Disease Risk among Asian American, Native Hawaiian, and other Pacific Islander Subgroups: The PANACHE Study

Alexeeff Stacey, Parikh Rishi, Daida Yihe, Ambrosy Andrew, Tan Thida, Lo Joan, Howick Connor, Go Alan

You have to be authorized to contact abstract author. Please, Login
Not Available